Premium Reports
Global (Non-US) EMR Market Share 2019

Global (Non-US) EMR Market Share 2019
Large Public Tenders Shape 2018 EMR Landscape

Authored by: Everton Santos and Jon Christensen May 2, 2019 | Read Time: 7  minutes

Current Time Inside Cache Tag Helper: 4/21/2021 1:42:55 AM and Model.reportId = 1460

In 2018, over 180 healthcare organizations outside the United States made EMR purchase decisions—impacting 377 hospitals (303 new wins, 74 migrations). Though public tenders represent just 5% of the contracts signed, they account for over a quarter of the hospitals impacted. Examining these and other EMR decisions, this report aims to determine how EMR vendors fared in 2018 so that organizations looking to buy know what their peers are selecting.

Healthcare Providers,
Want to see full details?

Not a Provider, contact us for pricing details.

Current Time Inside Cache Tag Helper: 4/21/2021 1:42:55 AM and Model.reportId = 1460

Key Findings

  1. Epic and Cerner Contracts Account for the Most New Beds among Multiregional Vendors
  2. Agfa HealthCare, Dedalus, and InterSystems Also Broadly Selected
  3. Europe: EMR Purchasing Picks Up in 2018; Agfa HealthCare (DACH), Cerner (Scandinavia & UK), and Dedalus (Mostly France) Benefit Most
  4. Latin America: MV Surging Ahead in Brazil; everis Growing in Other Countries
  5. Middle East & Africa: 2018 Purchasing Slow; Health Insights and InterSystems Selected in Largest Decisions
  6. Asia & Oceania: Epic and InterSystems Continue to Grow; ezCaretech expands in South Korea
  7. Canada: No Net New Contracts Signed
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.